Name
PKI-166
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--antiangiogenesis agent
NSC Number
None
Primary Site
Histology
None
Remarks
Phase II Signal transduction inhibitor. Novartis.
Coding
This drug should be coded